Leading science, pioneering therapies

CRM Publications

Found 6 results
Filters: Keyword is Case-Control Studies  [Clear All Filters]
2013
Boyd A, Zhang H, Williams AC.  2013.  Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.Acta Neuropathol. 125(6):841-59.
2012
Kan AA, van Erp S, Derijck AAHA, de Wit M, Hessel EVS, O'Duibhir E, de Jager W, Van Rijen PC, Gosselaar PH, de Graan PNE et al..  2012.  Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response.Cell Mol Life Sci. 69(18):3127-45.
Schoepf D, Potluri R, Uppal H, Natalwala A, Narendran P, Heun R.  2012.  Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up.Eur Psychiatry. 27(1):33-42.
2010
Skipworth RJE, Stewart GD, Bhana M, Christie J, Sturgeon CM, Guttridge DC, Cronshaw AD, Fearon KCH, Ross JA.  2010.  Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.Int J Oncol. 36(4):973-82.
2009
Mills NL, Tura O, Padfield GJ, Millar C, Lang NN, Stirling D, Ludlam C, Turner ML, Barclay GR, Newby DE.  2009.  Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention.Heart. 95(24):2003-8.
2004
Pals P, Lincoln S, Manning JR, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J et al..  2004.  alpha-Synuclein promoter confers susceptibility to Parkinson's disease.Ann Neurol. 56:591–595.